Cellebrite Di LTD

Ryusuke Utsumi, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Yonatan Domnitz, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Adam Clammer, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Buren Brandon Van, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Troy Richardson, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Dafna Gruber, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

True Wind Capital and its affiliates have filed an Amendment No. 3 to their Schedule 13D, updating their beneficial ownership in Cellebrite DI Ltd. to 5.8% of outstanding Ordinary Shares.

Voss Capital and affiliated entities have reported beneficial ownership of 12,700,000 ordinary shares, representing 5.1% of Cellebrite DI Ltd.'s outstanding stock.

SUNCORPORATION has filed an amendment to its Schedule 13G, confirming its beneficial ownership of 42.67% of Cellebrite DI Ltd.'s ordinary shares.

FMR LLC and Abigail P. Johnson have disclosed a reduction in their passive beneficial ownership stake in Cellebrite DI Ltd. to 4.1% of common stock as of March 31, 2025.

FMR LLC, the parent company of Fidelity Investments, has disclosed a 5.2% beneficial ownership stake in Cellebrite DI Ltd. as of December 31, 2024, held in the ordinary course of business.

An investment group, including IGP Saferworld and IGP Investments (G.P.L.P), has fully divested its beneficial ownership in Cellebrite DI Ltd. by December 31, 2024, while managing director Haim Shani retains a small individual holding.

SUNCORPORATION has reported a beneficial ownership of 43.7% of Cellebrite DI Ltd.'s ordinary shares, totaling 102,576,122 shares, as of December 31, 2024.